Subscribe

Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks
pharma-industry business earnings funding India

Aptus Pharma Debuts on BSE SME Platform Following Highly Subscribed IPO

Newsdesk profile image
by Newsdesk
Updated
Aptus Pharma Debuts on BSE SME Platform Following Highly Subscribed IPO

AI-Generated Summary

Aptus Pharma is set to debut on the BSE SME platform today after its initial public offering was oversubscribed more than 22 times, indicating significant investor demand from retail and high-net-worth individuals. The pharmaceutical formulations distributor reported strong revenue and profit growth, with IPO proceeds earmarked for working capital and new office infrastructure. This listing marks a significant financial milestone for the company within the pharmaceutical sector.

In a nutshell

This successful IPO reflects robust investor confidence in specialized pharmaceutical distribution companies, even within the SME segment. It highlights the continued appetite for growth opportunities in the healthcare sector's financial markets.

Source: The Economic Times

Newsdesk profile image
by Newsdesk
Updated

Be informed!

Rx.news delivers critical healthcare intelligence to pharmaceutical professionals, biotech innovators, healthcare investors, medical practitioners, and policy makers.

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Read More